Diffuse Cutaneous Systemic Sclerosis
📧 Sign up to get email alerts when something new happens for Diffuse Cutaneous Systemic Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Rapamycin vs Methotrexate in Diffuse SSc [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial comparing rapamycin versus methotrexate in diffuse systemic sclerosis.
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) [Phase 1, Phase 2]
Completed Phase 1/2 study evaluating abatacept for diffuse systemic sclerosis (scleroderma); results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial update reports safety, tolerability, and pharmacokinetics data for CAT-192, a human anti-TGF-beta1 monoclon…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma [Phase 2]
A Phase 2 proof-of-concept trial of imatinib (Gleevec) in active diffuse systemic sclerosis (scleroderma) has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-03-31Clinical Trial Update: Mycophenolate Mofetil in Systemic Sclerosis [Phase 1]
Phase 1 clinical trial of mycophenolate mofetil for diffuse cutaneous systemic sclerosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.